Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Global Transformation Infectious Disease Mitigation SummitUniversity of Texas – DallasVenture Development CenterDecember 3, 2014
2Introduction
Mark Stratton, Vice President M&S 25 years of disruptive technology development
Global systems and services implementations
Pathogen mobility analysis and solution modeling
Brian Searcy, Vice President Operations 30 years of advanced technology deployment
Standup and mature global support management
Pathogen inhibitor best practices and education
For WAACCI and E-Mist Innovations use only.
3
E-Mist Innovations DeliversSurface Transferrable Pathogen Management
Thirty year veterans in surface inhibitor application technology development
Mission: To consistently interrupt the mobility of infectious pathogens
Vision: Through continuous application technology innovation and superior manufacturing, empower everyone to achieve healthy surface touch point environments simply and cost effectively
For WAACCI and E-Mist Innovations use only.
4
Ingress Pathogens Misguided Focus
Pathogen Mobility
Airlines & Transport
Hospital & Medical
Education & Athletics
Food Processing & Agriculture
Office -Retail
Restaurants
Hospitality & Lodging
Government & Military
Residential & Long Term
Care
• Arriving pathogens uncontrollable
• Resident pathogens become custody of surface environment owner
• Interruption of mobility a more practical and achievable goal
For WAACCI and E-Mist Innovations use only.
5
Egress Pathogen Strategy Is Working Limited
Pathogen Mobility Overlap
Airlines & Transport
Hospital & Medical
Education & Athletics
Food Processing & Agriculture
Office -Retail
Restaurants
Hospitality & Lodging
Government & Military
Residential & Long Term
Care
• Allowing egress irresponsible
• Proper surface disinfection interrupting continual chain of mobility
• Collaboration of surface owners under way
For WAACCI and E-Mist Innovations use only.
Ingress
Egress
6The Gap Between Effort And Results
The expectation is that cleaning while disinfecting is delivering healthy touch point surfaces
Spraying-and-wiping, in particular, cancels disinfectant effectiveness - and touching surfaces spreads pathogens every time
New options are closing the gap between healthy surface expectations and current effort shortfalls
For WAACCI and E-Mist Innovations use only.
7Proper Surface Disinfection
Establish disinfection steps separate from cleaning
Disinfection needs exceed cleaning capabilities
Align strategy with actual pathogen behaviors
Fully leverage disinfectant delivery technology advancements
Frequency
Agent
Coverage
Touchless
Safety
F
A
C
T
S
For WAACCI and E-Mist Innovations use only.
8
E-Mister Surface Disinfection Management System
Basic skill-level operation
Mobile, agile, flexible
Two component system
Rolling battery pack & tank
Quick connect E-Misting wand
Simple tank flushing
Simple battery recharge
Lifetime replacement and support
For WAACCI and E-Mist Innovations use only.
9
E-Mister Details
Patented electrostatic droplet delivery
Liquid-efficient droplet adhesion
Non-inhalation droplet sizing and shaping
Delivers any water soluble agent
Disinfection and odor management
Average 6,000 touch point treatments per tank
Single battery operation – spare provided
Quiet, light weight wand
Hardened case with easy fill cap
USA manufacturing within ISO 9001:2008, ISO 13485:2003, FDA Registration 1648571
For WAACCI and E-Mist Innovations use only.
10
E-MisterAircraft Cabin Example
Volume of high priority touch points demonstrates the need for new application technology in order to be successful
Boeing 737-800 150 seats
14 average seat surface touch points
2,100 average total seat surface high use surface touch points
Unhealthy touch point disinfection results Less than 10 minutes
Average Single Seat Touch Points Including Safety Belts: 14
For WAACCI and E-Mist Innovations use only.
11
Simple And Complex In-Service Environments
Preventative in-service: Hospitals
Nursing homes
School districts
Entertainment venues
Outbreak in-service: Ebola
Influenza
Norovirus
Staphylococcus
Escherichia coli
Clostridium difficile
For WAACCI and E-Mist Innovations use only.
12
FACTS™
Proper Surface Management And Disinfection Comparison
FACTS™ Proper Surface Management And Disinfection Protocol
Ability To Meet Goals With Current Methods
Ability To Meet Goals With Touch Point Healthy E-Mister
Frequency
Agent
Coverage
Touchless
Safety
For WAACCI and E-Mist Innovations use only.
13
E-Mist Innovations
Thank You!
844.56E-MIST
TouchPointHealthy.com
Touch Point Healthy Surface Management Systems™
ISO 9001:2008
ISO 13485:2003
FDA Reg: 1648571
Patent US8746597
© 2014 All Rights Reserved
For WAACCI and E-Mist Innovations use only.